AW
MDXG icon

ACG Wealth’s MiMedx Group MDXG Stock Holding History

ACG Wealth’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,720
Closed -$9K – 703
2022
Q2 		$9K Buy
+2,720
New +$10.7K ﹤0.01% 711

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACG Wealth's MDXG Position: Q3 2022 in Review

ACG Wealth sold out of MiMedx Group (MDXG) in Q3 2022, closing a stake of 2,720 shares — an estimated $9K sold.

ACG Wealth first reported a position in MDXG in Q2 2022 and held it in 1 quarter. The position peaked at $9K in Q2 2022. 144 funds tracked by Wall St. Rank hold MDXG as of Q3 2022.

  • ACG Wealth reported no remaining MiMedx Group position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 2,720 MiMedx Group shares in Q3 2022, an estimated $9K.
  • ACG Wealth first reported a position in MiMedx Group in Q2 2022 and held it in 1 quarter.
  • ACG Wealth's MiMedx Group position peaked at $9K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.